Creating an Innovation Engine to Advance Medicine for Patients with Rare Diseases.

Saved in:
Bibliographic Details
Title: Creating an Innovation Engine to Advance Medicine for Patients with Rare Diseases.
Authors: Gallagher, Thomas
Source: Human Gene Therapy; Jan2025, Vol. 36 Issue 1/2, p1-6, 6p
Subject Terms: PATIENTS' attitudes, MEDICAL sciences, OPEN Data Protocol, SEVERE combined immunodeficiency, POOR communities, GAIN-of-function mutations
Abstract: The article "Creating an Innovation Engine to Advance Medicine for Patients with Rare Diseases" discusses the efforts of patient advocate Rufang (Kevin) Huang and various organizations to drive advancements in rare disease research and treatment. The focus is on developing innovative approaches to overcome challenges in research, funding, clinical trials, and patient access to new medicines. The article highlights the need for international cooperation, standardized protocols, and novel funding mechanisms to accelerate the development of treatments for the over 7,000 identified rare diseases. It emphasizes the importance of understanding genotype-phenotype relationships, innovative screening methods, preclinical research strategies, and funding mechanisms to bridge the gap between promising therapies and patient access. [Extracted from the article]
Copyright of Human Gene Therapy is the property of Mary Ann Liebert, Inc. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Biomedical Index
Description
Abstract:The article "Creating an Innovation Engine to Advance Medicine for Patients with Rare Diseases" discusses the efforts of patient advocate Rufang (Kevin) Huang and various organizations to drive advancements in rare disease research and treatment. The focus is on developing innovative approaches to overcome challenges in research, funding, clinical trials, and patient access to new medicines. The article highlights the need for international cooperation, standardized protocols, and novel funding mechanisms to accelerate the development of treatments for the over 7,000 identified rare diseases. It emphasizes the importance of understanding genotype-phenotype relationships, innovative screening methods, preclinical research strategies, and funding mechanisms to bridge the gap between promising therapies and patient access. [Extracted from the article]
ISSN:10430342
DOI:10.1089/hum.2024.98456